Literature DB >> 6834846

Usefulness of preoperative CEA levels in the assessment of colorectal cancer patient stage.

G Midiri, C Amanti, F Consorti, M Benedetti, S Del Buono, U Di Tondo, G Castagna, L Peronace, M Di Paola.   

Abstract

In order to demonstrate a prognostic value of preoperative CEA levels, we have tried to define a correlation between CEA and histologic stage of tumor in 124 patients with colorectal carcinoma. CEA concentration has been evaluated by radioimmunologic assay and the histologic stage following Dukes' classification. The results show a 25.0% positivity rate for patients in stage A, 48.2% for stage B, 61.1% for stage C, and 85.7% for stage D. The mean CEA values are 7.8 ng/ml in the first group, 30.3 ng/ml in the second, 58.1 ng/ml in the third, and 134.3 ng/ml in the last group. Furthermore, we have tried to relate the histopathologic grade of the tumor (G) with CEA levels in 54 patients of the 124. We conclude that preoperative CEA has a prognostic value, and it is useful in the staging of colorectal cancer patients. A low concentration indicates an early stage of the tumor, while a high concentration indicates a wide spread of disease; on the other hand, there are not significant correlations with cancer grading.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6834846     DOI: 10.1002/jso.2930220410

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.

Authors:  Gota Saito; Sotaro Sadahiro; Hiroko Kamata; Hiroshi Miyakita; Kazutake Okada; Akira Tanaka; Toshiyuki Suzuki
Journal:  Oncology       Date:  2017-02-09       Impact factor: 2.935

2.  Differences in carcinoembryonic antigen levels between colon and rectal cancer.

Authors:  Yunlong Ding; Weibo Xuan; Chunlin Chen; Zhe Chen; Ziyi Yang; Yunfei Zuo; Shuangyi Ren
Journal:  Mol Clin Oncol       Date:  2014-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.